This inventor holds 2 USPTO granted patents. Top assignee: Neurogen Corporation. Active years: 2006-2008.
Company Filing History:
Years Active: 2006-2008
Title: **Highlighting the Innovations of Inventor Stéphane DeLombaert**
Introduction
Stéphane DeLombaert is an accomplished inventor based in Madison, Connecticut. He is recognized for his significant contributions to pharmaceutical research, particularly in the realm of receptor modulators. With one patent to his name, he has made strides in understanding and treating various conditions related to receptor activation.
Latest Patents
DeLombaert’s patent focuses on "Carboxylic acid, phosphate or phosphonate substituted quinazolin-4-ylamine analogues as capsaicin receptor modulators." This innovative work highlights the potential of acid-substituted quinazolin-4-ylamine analogues, which serve as ligands to modulate specific receptor activity both in vivo and in vitro. These compounds are particularly valuable for treating conditions associated with pathological receptor activation in humans and domesticated animals. His research also encompasses the development of pharmaceutical compositions and methodologies for utilizing these ligands in receptor localization studies.
Career Highlights
Throughout his career at Neurogen Corporation, Stéphane DeLombaert has played a pivotal role in advancing drug development and therapeutic strategies. His expertise and focused research have positioned him as a knowledgeable figure in his field, contributing to the company’s mission of delivering innovative medical solutions.
Collaborations
Stéphane collaborates closely with esteemed colleagues such as Rajagopal Bakthavatchalam and Charles A. Blum. Their combined efforts enhance the research capabilities at Neurogen Corporation and drive the exploration of novel therapeutic agents.
Conclusion
As an inventor, Stéphane DeLombaert exemplifies the spirit of innovation in the pharmaceutical industry through his focused research and patent contributions. His work continues to pave the way for new treatments and understanding of receptor modulators, making a significant impact in the field of medical science.